Objectives:To provide data on the safety and efficacy of renal arterial embolization(RAE)in patients with highgrade blunt renal injury.Materials and methods:Fifteen patients with high-grade blunt renal injury(AAST gra...Objectives:To provide data on the safety and efficacy of renal arterial embolization(RAE)in patients with highgrade blunt renal injury.Materials and methods:Fifteen patients with high-grade blunt renal injury(AAST grades IV-V)admitted to our hospital from July 2014 to December 2019 were retrospectively reviewed in this study.Their clinical success rate and complications were investigated accordingly.Results:Fifteen patients with high-grade blunt renal injury,13 men and 2 women with an average age of 41.6 years,including 11 hemodynamically unstable patients and 4 stable patients,were treated with RAE.Among these patients,73.3%(11 of 15)had grade IV,and 26.7%(4 of 15)had grade V injuries,while 53.3%(8 of 15)patients had concomitant injuries.One patient received main RAE and 14 patients received selective RAE.The clinical success rate after the first embolization was 93.3%(14 of 15).RAE was repeated and was successfully performed in one patient with sustained hematuria.No significant difference in creatinine levels was found before and after embolization.During the follow-up period of 2–82 months,two patients required tube drainage due to urine leaks,one patient developed renal failure requiring renal replacement therapy,and one patient developed secondary hypertension.Conclusions:RAE can provide a high success rate of hemostasis for both hemodynamically stable and unstable patients with high-grade blunt renal injury,and only minor complications are observed with this procedure.展开更多
The treatment and repair of bone tissue damage and loss due to infection,tumours,and trauma are major challenges in clinical practice.Artificial bone scaffolds offer a safer,simpler,and more feasible alternative to bo...The treatment and repair of bone tissue damage and loss due to infection,tumours,and trauma are major challenges in clinical practice.Artificial bone scaffolds offer a safer,simpler,and more feasible alternative to bone transplantation,serving to fill bone defects and promote bone tissue regeneration.Ideally,these scaffolds should possess osteoconductive,osteoinductive,and osseointegrative properties.However,the current first-generation implants,represented by titanium alloys,have shown poor bone-implant integration performance and cannot meet the requirements for bone tissue repair.This has led to increased research on second and third generation artificial bone scaffolds,which focus on loading bioactive molecules and cells.Polymer microspheres,known for their high specific surface areas at the micro-and nanoscale,exhibit excellent cell and drug delivery behaviours.Additionally,with their unique rigid structure,microsphere scaffolds can be constructed using methods such as thermal sintering,injection,and microsphere encapsulation.These scaffolds not only ensure the excellent cell drug loading performance of microspheres but also exhibit spatial modulation behaviour,aiding in bone repair within a three-dimensional network structure.This article provides a summary and discussion of the use of polymer microsphere scaffolds for bone repair,focusing on the mechanisms of bone tissue repair and the current status of clinical bone grafts,aimed at advancing research in bone repair.展开更多
基金supported by a research start-up fund for talent introduction of the Second Affiliated Hospital of Hainan Medical University。
文摘Objectives:To provide data on the safety and efficacy of renal arterial embolization(RAE)in patients with highgrade blunt renal injury.Materials and methods:Fifteen patients with high-grade blunt renal injury(AAST grades IV-V)admitted to our hospital from July 2014 to December 2019 were retrospectively reviewed in this study.Their clinical success rate and complications were investigated accordingly.Results:Fifteen patients with high-grade blunt renal injury,13 men and 2 women with an average age of 41.6 years,including 11 hemodynamically unstable patients and 4 stable patients,were treated with RAE.Among these patients,73.3%(11 of 15)had grade IV,and 26.7%(4 of 15)had grade V injuries,while 53.3%(8 of 15)patients had concomitant injuries.One patient received main RAE and 14 patients received selective RAE.The clinical success rate after the first embolization was 93.3%(14 of 15).RAE was repeated and was successfully performed in one patient with sustained hematuria.No significant difference in creatinine levels was found before and after embolization.During the follow-up period of 2–82 months,two patients required tube drainage due to urine leaks,one patient developed renal failure requiring renal replacement therapy,and one patient developed secondary hypertension.Conclusions:RAE can provide a high success rate of hemostasis for both hemodynamically stable and unstable patients with high-grade blunt renal injury,and only minor complications are observed with this procedure.
基金supported by the National Natural Science Foundation of China(Nos.82402822,32200559,82372425)Natural Science Foundation of Sichuan Province(Nos.NSFSC5880,NSFSC1291)+2 种基金Chengdu Medical Research Project(No.2022004)Natural Science Foundation of Clinical Medical College and Affiliated Hospital of Chengdu University(No.Y202206)China Postdoctoral Science Foundation(No.2021M702364).
文摘The treatment and repair of bone tissue damage and loss due to infection,tumours,and trauma are major challenges in clinical practice.Artificial bone scaffolds offer a safer,simpler,and more feasible alternative to bone transplantation,serving to fill bone defects and promote bone tissue regeneration.Ideally,these scaffolds should possess osteoconductive,osteoinductive,and osseointegrative properties.However,the current first-generation implants,represented by titanium alloys,have shown poor bone-implant integration performance and cannot meet the requirements for bone tissue repair.This has led to increased research on second and third generation artificial bone scaffolds,which focus on loading bioactive molecules and cells.Polymer microspheres,known for their high specific surface areas at the micro-and nanoscale,exhibit excellent cell and drug delivery behaviours.Additionally,with their unique rigid structure,microsphere scaffolds can be constructed using methods such as thermal sintering,injection,and microsphere encapsulation.These scaffolds not only ensure the excellent cell drug loading performance of microspheres but also exhibit spatial modulation behaviour,aiding in bone repair within a three-dimensional network structure.This article provides a summary and discussion of the use of polymer microsphere scaffolds for bone repair,focusing on the mechanisms of bone tissue repair and the current status of clinical bone grafts,aimed at advancing research in bone repair.
